Not applicableStudy completedNCT01532726What this trial is testingEslicarbazepine Acetate as Add-On Treatment to One Baseline Antiepileptic Drug (ESLADOBA)Who this might be right forEpilepsy Bial - Portela C S.A. 56
Large-scale testing (Phase 3)Study completedNCT03250377What this trial is testingTest the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary GeneralizationWho this might be right forPartial Seizures With or Without Secondary GeneralizationEpilepsy UCB Biopharma SRL 207
Not applicableStudy completedNCT02687711What this trial is testingStudy to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset SeizuresWho this might be right forEpilepsy With POS With or Without Secondary Generalization UCB Biopharma S.P.R.L. 544
Testing effectiveness (Phase 2)Ended earlyNCT04529954What this trial is testingAnti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF InfusionWho this might be right forFocal Epilepsy Cerebral Therapeutics LLC 20
Post-approval studies (Phase 4)Study completedNCT02726074What this trial is testingTrial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary GeneralizationWho this might be right forEpilepsy Eisai Korea Inc. 106
Not applicableStudy completedNCT01673282What this trial is testingStudy Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination TherapyWho this might be right forFocal Epilepsy With and Without Secondary Generalization UCB Pharma GmbH 315
Testing effectiveness (Phase 2)Study completedNCT00800215What this trial is testingA Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927Who this might be right forEpilepsy UCB Pharma 60
Large-scale testing (Phase 3)Study completedNCT02192814What this trial is testingOpen-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset SeizuresWho this might be right forEpilepsyPartial-onset Seizures UCB Japan Co. Ltd. 9
Large-scale testing (Phase 3)Ended earlyNCT00698581What this trial is testingA Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset SeizuresWho this might be right forEpilepsy UCB Pharma 88
Large-scale testing (Phase 3)Study completedNCT01710657What this trial is testingA Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset SeizuresWho this might be right forEpilepsyPartial Onset Seizures UCB Pharma SA 548
Large-scale testing (Phase 3)Study completedNCT02124564What this trial is testingA Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset SeizuresWho this might be right forEpilepsyPartial-onset Seizures UCB Japan Co. Ltd. 19
Large-scale testing (Phase 3)Study completedNCT01832038What this trial is testingStudy to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset SeizuresWho this might be right forEpilepsyPartial-onset Seizures UCB Pharma SA 473
Not applicableStudy completedNCT04252846What this trial is testingInvestigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized EpilepsyWho this might be right forIdiopathic Generalized EpilepsyPartial Onset SeizuresGeneralised Tonic-Clonic Seizures Eisai Limited 191
Not applicableStudy completedNCT01098162What this trial is testingVimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic DrugWho this might be right forEpilepsies, Partial UCB Pharma GmbH 576
Large-scale testing (Phase 3)Study completedNCT03083665What this trial is testingEvaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With EpilepsyWho this might be right forPartial Seizures With or Without Secondary GeneralizationEpilepsy UCB Biopharma SRL 449
Not applicableStudy completedNCT01620840What this trial is testingLacosamid-i.v.-RegisterWho this might be right forEpilepsy With Partial Onset Seizures With or Without Secondary Generalization University Hospital Schleswig-Holstein 130
Large-scale testing (Phase 3)Study completedNCT00220415What this trial is testingA Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary GeneralizationWho this might be right forPartial Seizures With or Without Secondary Generalization UCB Pharma
Large-scale testing (Phase 3)Study completedNCT01392768What this trial is testingEfficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary GeneralizationWho this might be right forEpilepsyPartial Seizures Ache Laboratorios Farmaceuticos S.A. 126
Testing effectiveness (Phase 2)Study completedNCT00210652What this trial is testingAn Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With EpilepsyWho this might be right forEpilepsyEpilepsies, Partial SK Life Science, Inc. 47
Large-scale testing (Phase 3)Ended earlyNCT00699283What this trial is testingA Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset SeizuresWho this might be right forEpilepsy UCB Pharma 62